Stockreport

Rapport Announces Pricing of Public Offering of Common Stock

Rapport Therapeutics, Inc.  (RAPP) 
PDF BOSTON and SAN DIEGO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company [Read more]